ID   ZC12A_RAT               Reviewed;         596 AA.
AC   A0JPN4;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 1.
DT   24-JUL-2024, entry version 103.
DE   RecName: Full=Endoribonuclease ZC3H12A {ECO:0000305};
DE            EC=3.1.-.- {ECO:0000250|UniProtKB:Q5D1E7};
DE   AltName: Full=Monocyte chemotactic protein-induced protein 1 {ECO:0000250|UniProtKB:Q5D1E7};
DE            Short=MCP-induced protein 1 {ECO:0000250|UniProtKB:Q5D1E7};
DE            Short=MCPIP-1 {ECO:0000250|UniProtKB:Q5D1E7};
DE   AltName: Full=Regnase-1 {ECO:0000250|UniProtKB:Q5D1E7};
DE            Short=Reg1 {ECO:0000250|UniProtKB:Q5D1E7};
DE   AltName: Full=Zinc finger CCCH domain-containing protein 12A {ECO:0000312|RGD:1306776};
GN   Name=Zc3h12a {ECO:0000312|RGD:1306776};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:AAI27517.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart {ECO:0000312|EMBL:AAI27517.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Endoribonuclease involved in various biological functions
CC       such as cellular inflammatory response and immune homeostasis, glial
CC       differentiation of neuroprogenitor cells, cell death of cardiomyocytes,
CC       adipogenesis and angiogenesis. Functions as an endoribonuclease
CC       involved in mRNA decay. Modulates the inflammatory response by
CC       promoting the degradation of a set of translationally active cytokine-
CC       induced inflammation-related mRNAs, such as IL6 and IL12B, during the
CC       early phase of inflammation. Prevents aberrant T-cell-mediated immune
CC       reaction by degradation of multiple mRNAs controlling T-cell
CC       activation, such as those encoding cytokines (IL6 and IL2), cell
CC       surface receptors (ICOS, TNFRSF4 and TNFR2) and transcription factor
CC       (REL). Inhibits cooperatively with ZC3H12A the differentiation of
CC       helper T cells Th17 in lungs. They repress target mRNA encoding the
CC       Th17 cell-promoting factors IL6, ICOS, REL, IRF4, NFKBID and NFKBIZ.
CC       The cooperation requires RNA-binding by RC3H1 and the nuclease activity
CC       of ZC3H12A (By similarity). Together with RC3H1, destabilizes
CC       TNFRSF4/OX40 mRNA by binding to the conserved stem loop structure in
CC       its 3'UTR (By similarity). Self regulates by destabilizing its own
CC       mRNA. Cleaves mRNA harboring a stem-loop (SL), often located in their
CC       3'-UTRs, during the early phase of inflammation in a helicase UPF1-
CC       dependent manner (By similarity). Plays a role in the inhibition of
CC       microRNAs (miRNAs) biogenesis (By similarity). Cleaves the terminal
CC       loop of a set of precursor miRNAs (pre-miRNAs) important for the
CC       regulation of the inflammatory response leading to their degradation,
CC       and thus preventing the biosynthesis of mature miRNAs (By similarity).
CC       Also plays a role in promoting angiogenesis in response to inflammatory
CC       cytokines by inhibiting the production of antiangiogenic microRNAs via
CC       its anti-dicer RNase activity (By similarity). Affects the overall
CC       ubiquitination of cellular proteins. Positively regulates
CC       deubiquitinase activity promoting the cleavage at 'Lys-48'- and 'Lys-
CC       63'-linked polyubiquitin chains on TNF receptor-associated factors
CC       (TRAFs), preventing JNK and NF-kappa-B signaling pathway activation,
CC       and hence negatively regulating macrophage-mediated inflammatory
CC       response and immune homeostasis (By similarity). Induces also
CC       deubiquitination of the transcription factor HIF1A, probably leading to
CC       its stabilization and nuclear import, thereby positively regulating the
CC       expression of proangiogenic HIF1A-targeted genes. Involved in a TANK-
CC       dependent negative feedback response to attenuate NF-kappaB activation
CC       through the deubiquitination of IKBKG or TRAF6 in response to
CC       interleukin-1-beta (IL1B) stimulation or upon DNA damage (By
CC       similarity). Prevents stress granules (SGs) formation and promotes
CC       macrophage apoptosis under stress conditions, including arsenite-
CC       induced oxidative stress, heat shock, and energy deprivation. Plays a
CC       role in the regulation of macrophage polarization; promotes IL4-induced
CC       polarization of macrophages M1 into anti-inflammatory M2 state. May
CC       also act as a transcription factor that regulates the expression of
CC       multiple genes involved in inflammatory response, angiogenesis,
CC       adipogenesis and apoptosis (By similarity). Functions as a positive
CC       regulator of glial differentiation of neuroprogenitor cells through an
CC       amyloid precursor protein (APP)-dependent signaling pathway (By
CC       similarity). Attenuates septic myocardial contractile dysfunction in
CC       response to lipopolysaccharide (LPS) by reducing I-kappa-B-kinase
CC       (IKK)-mediated NF-kappa-B activation, and hence myocardial pro-
CC       inflammatory cytokine production (By similarity).
CC       {ECO:0000250|UniProtKB:Q5D1E7, ECO:0000250|UniProtKB:Q5D1E8}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q5D1E7};
CC       Note=Mg(2+) is required for RNase activity.
CC       {ECO:0000250|UniProtKB:Q5D1E7};
CC   -!- SUBUNIT: Oligomer. Found in a deubiquitination complex with TANK, USP10
CC       and ZC3H12A; this complex inhibits genotoxic stress- or interleukin-1-
CC       beta-mediated NF-kappaB activation by promoting IKBKG or TRAF6
CC       deubiquitination. Interacts with IKBKG; this interaction increases in
CC       response to DNA damage. Interacts with TANK; this interaction increases
CC       in response to DNA damage and serves as a bridge to anchor both TANK
CC       and USP10 into a deubiquitinating complex. Interacts with TRAF6; this
CC       interaction increases in response to DNA damage and is stimulated by
CC       TANK. Interacts with USP10; this interaction increases in response to
CC       DNA damage and serves as a bridge to anchor both TANK and USP10 into a
CC       deubiquitinating complex. Interacts with ZC3H12D. Interacts with
CC       TNRC6A. Interacts with IKBKB/IKKB. Interacts with IKBKB/IKKB. Interacts
CC       with IKBKB/IKKB. Interacts with BTRC; the interaction occurs when
CC       ZC3H12A is phosphorylated in a IKBKB/IKKB-dependent manner. Interacts
CC       with IRAK1; this interaction increases the interaction between ZC3H12A
CC       and IKBKB/IKKB. Interacts with UPF1; this interaction occurs in a mRNA
CC       translationally active- and termination-dependent manner and is
CC       essential for ZC3H12A-mediated degradation of target mRNAs. Associates
CC       with ribosomes. Interacts with ubiquitin.
CC       {ECO:0000250|UniProtKB:Q5D1E7, ECO:0000250|UniProtKB:Q5D1E8}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5D1E7}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q5D1E7}. Rough endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q5D1E7}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q5D1E7}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q5D1E7}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:Q5D1E7}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:Q5D1E8}. Note=Predominantly localized in the
CC       cytoplasm. Colocalizes with GW182 on many granule-like structures,
CC       probably corresponding to cytoplasmic GW bodies (GWBs), also called
CC       processing bodies (P bodies). Colocalizes with calnexin on the surface
CC       of the rough endoplasmic reticulum (RER) membrane and with
CC       translationally active polysomes. Colocalizes with ZC3H12D in
CC       cytoplasmic mRNA processing P-body, also known as GW bodies (GWBs).
CC       {ECO:0000250|UniProtKB:Q5D1E7, ECO:0000250|UniProtKB:Q5D1E8}.
CC   -!- DOMAIN: The C3H1-type zinc finger domain and C-terminal region are
CC       necessary for pre-miRNA binding. The C-terminal region and proline-rich
CC       domain are necessary for oligomerization.
CC       {ECO:0000250|UniProtKB:Q5D1E8}.
CC   -!- PTM: Phosphorylated by IRAK1; phosphorylation is necessary for
CC       subsequent phosphorylation by the I-kappa-B-kinase (IKK) complex.
CC       Phosphorylated by I-kappa-B-kinases (IKKs) at Ser-435 and Ser-439 upon
CC       lipopolysaccharide (LPS) or IL1B stimulation in macrophages through the
CC       MyD88-dependent signaling pathway; these phosphorylations promote rapid
CC       ubiquitin proteasome-mediated degradation of ZC3H12A in macrophages and
CC       hence allows its target mRNAs, such as IL6, to escape from degradation
CC       and accumulate during the inflammatory response.
CC       {ECO:0000250|UniProtKB:Q5D1E7}.
CC   -!- PTM: Ubiquitinated; ubiquitination is induced in response to
CC       interleukin IL1 receptor stimuli in a IKBKB/IKKB and IRAK1-dependent
CC       manner, leading to proteasome-mediated degradation.
CC       {ECO:0000250|UniProtKB:Q5D1E7}.
CC   -!- PTM: Proteolytically cleaved between Arg-111 and Arg-214 by MALT1 in
CC       activated T-cells; cleavage at Arg-111 is critical for promoting
CC       ZC3H12A degradation in response to T-cell receptor (TCR) stimulation,
CC       and hence is necessary for prolonging the stability of a set of mRNAs
CC       controlling T-cell activation and Th17 cell differentiation.
CC       {ECO:0000250|UniProtKB:Q5D1E7}.
CC   -!- SIMILARITY: Belongs to the ZC3H12 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC127516; AAI27517.1; -; mRNA.
DR   RefSeq; NP_001071139.1; NM_001077671.1.
DR   AlphaFoldDB; A0JPN4; -.
DR   SMR; A0JPN4; -.
DR   STRING; 10116.ENSRNOP00000012314; -.
DR   iPTMnet; A0JPN4; -.
DR   PhosphoSitePlus; A0JPN4; -.
DR   PaxDb; 10116-ENSRNOP00000012314; -.
DR   Ensembl; ENSRNOT00000012314.7; ENSRNOP00000012314.4; ENSRNOG00000009131.7.
DR   Ensembl; ENSRNOT00055021722; ENSRNOP00055017607; ENSRNOG00055012716.
DR   Ensembl; ENSRNOT00060023620; ENSRNOP00060018774; ENSRNOG00060013827.
DR   Ensembl; ENSRNOT00065029865; ENSRNOP00065023711; ENSRNOG00065017849.
DR   GeneID; 313587; -.
DR   KEGG; rno:313587; -.
DR   UCSC; RGD:1306776; rat.
DR   AGR; RGD:1306776; -.
DR   CTD; 80149; -.
DR   RGD; 1306776; Zc3h12a.
DR   eggNOG; KOG3777; Eukaryota.
DR   GeneTree; ENSGT00940000155107; -.
DR   HOGENOM; CLU_013020_2_1_1; -.
DR   InParanoid; A0JPN4; -.
DR   OMA; WSEPYQM; -.
DR   OrthoDB; 180910at2759; -.
DR   PhylomeDB; A0JPN4; -.
DR   PRO; PR:A0JPN4; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000009131; Expressed in duodenum and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0030867; C:rough endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0004518; F:nuclease activity; ISS:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0004521; F:RNA endonuclease activity; ISS:UniProtKB.
DR   GO; GO:0004532; F:RNA exonuclease activity; ISS:UniProtKB.
DR   GO; GO:0004540; F:RNA nuclease activity; ISO:RGD.
DR   GO; GO:0035613; F:RNA stem-loop binding; ISS:UniProtKB.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:1990869; P:cellular response to chemokine; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISO:RGD.
DR   GO; GO:1904637; P:cellular response to ionomycin; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:1903936; P:cellular response to sodium arsenite; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0002757; P:immune response-activating signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0010587; P:miRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; ISO:RGD.
DR   GO; GO:0044828; P:negative regulation by host of viral genome replication; ISO:RGD.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0055118; P:negative regulation of cardiac muscle contraction; ISS:UniProtKB.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0010656; P:negative regulation of muscle cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:1901223; P:negative regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISO:RGD.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0010884; P:positive regulation of lipid storage; ISO:RGD.
DR   GO; GO:2000627; P:positive regulation of miRNA catabolic process; ISO:RGD.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:1903003; P:positive regulation of protein deubiquitination; ISS:UniProtKB.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; ISO:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0051259; P:protein complex oligomerization; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB.
DR   CDD; cd18729; PIN_Zc3h12-like; 1.
DR   Gene3D; 3.40.50.11980; -; 1.
DR   InterPro; IPR040546; Rege-1_UBA-like.
DR   InterPro; IPR040757; Regnase_1/ZC3H12_C.
DR   InterPro; IPR021869; RNase_Zc3h12_NYN.
DR   InterPro; IPR051101; ZC3H12/N4BP1_RNase_Reg.
DR   PANTHER; PTHR12876:SF10; ENDORIBONUCLEASE ZC3H12A; 1.
DR   PANTHER; PTHR12876; N4BP1-RELATED; 1.
DR   Pfam; PF18561; Regnase_1_C; 1.
DR   Pfam; PF11977; RNase_Zc3h12a; 1.
DR   Pfam; PF18039; UBA_6; 1.
PE   2: Evidence at transcript level;
KW   Angiogenesis; Apoptosis; Cytoplasm; Developmental protein; Differentiation;
KW   DNA damage; DNA-binding; Endonuclease; Endoplasmic reticulum; Hydrolase;
KW   Immunity; Inflammatory response; Magnesium; Membrane; Metal-binding;
KW   Neurogenesis; Nuclease; Nucleus; Phosphoprotein; Reference proteome;
KW   RNA-binding; Stress response; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..596
FT                   /note="Endoribonuclease ZC3H12A"
FT                   /id="PRO_0000341514"
FT   DOMAIN          135..290
FT                   /note="RNase NYN"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         301..324
FT                   /note="C3H1-type"
FT   REGION          24..44
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          42..87
FT                   /note="Ubiquitin association domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E7"
FT   REGION          81..150
FT                   /note="Necessary for interaction with TANK"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   REGION          92..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          112..281
FT                   /note="RNase"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   REGION          214..220
FT                   /note="RNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   REGION          278..306
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          301..454
FT                   /note="Necessary for interaction with ZC3H12D"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   REGION          339..415
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          447..467
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          517..542
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        288..306
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        349..370
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        387..402
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         226
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E8"
FT   MOD_RES         435
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E7"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5D1E7"
SQ   SEQUENCE   596 AA;  65927 MW;  C2BBA6DF323432AE CRC64;
     MSDPCGKKLV QEISPTMSLW GLEDRHSCQG QPQPDQDPVA KEASASELQM KVDFFRKLGY
     SSSEIHSALQ KLGVQADTNT VLGELVKHGS ATERECQAST DPCPQPPLVP RGGSTPKPST
     VEPSLPEEDK ESSDLRPVVI DGSNVAMSHG NKEVFSCRGI LLAVNWFLER GHTDITVFVP
     SWRKEQPRPD VPITDQHILR ELEKKKILVF TPSRRVGGKR VVCYDDRFIV KLAYESDGVV
     VSNDTYRDLQ GERQEWKRFI EERLLMYSFV NDKFMPPDDP LGRHGPSLDN FLRKKPLPSE
     HRKQPCPYGR KCTYGIKCRF FHPERPSRPQ RSVADELRAN ALLSPPRTPV KDKSSQRPSP
     ASQPNSMSLE AEPGSPDGKK LGTRSSPGPH QEGSTQTCAP AGRSLPVSGG SFGPTEWLPH
     TLDSLPYTSQ ECLDSGIGSL ESQMSELWGL RGGSPGESGP TRGPYTGYQT YGSKLPAAPA
     FSPFRQAIGT GHFSVPTDYV PPPPTYPARE YWSEPYPLPP PTPVLQEPQR PRPRASGDPW
     GRVSDLAKER AGVYTKLCGV FPPHLVEAVM GRFPQLLDPQ QLAAEILSYK SQHLSE
//
